| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/30/1992 | EP0506011A1 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
| 09/30/1992 | EP0505604A1 Highly purified thrombin preparation |
| 09/30/1992 | EP0505553A1 Cloned leuconostoc mesenteroides glucose-6-phosphate dehydrogenase genes and method of making same |
| 09/30/1992 | EP0505440A1 Genetic control of ethylene biosynthesis in plants |
| 09/30/1992 | EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents |
| 09/30/1992 | EP0354916B1 Neutralization of heparin |
| 09/30/1992 | CA2107208A1 Methods for treating cotton-containing fabrics with cellulase |
| 09/30/1992 | CA2107206A1 Methods for treating cotton-containing fabrics with cellulase |
| 09/30/1992 | CA2105559A1 Alkaline protease 3733, its production and use in cleaning contact lens |
| 09/30/1992 | CA2063892A1 Alpha-lytic protease cleaning compositions |
| 09/30/1992 | CA2062406A1 Ganglioside gm3 analogs |
| 09/30/1992 | CA2062369A1 Thioglycoside analogs of gangliosides |
| 09/29/1992 | WO1992017593A1 Bifunctional genetic markers |
| 09/29/1992 | US5151513 N-heterocyclic alcohol derivatives |
| 09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 09/29/1992 | US5151364 Expression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmids |
| 09/29/1992 | US5151359 P-aminomethylbenzoic acid in a cell culture, incubation |
| 09/29/1992 | US5151358 Processes for the recovery of naturally produced chymosin |
| 09/29/1992 | US5151355 Process for the production of high purity thrombin |
| 09/29/1992 | US5151354 Production of ethanol by culture of saccharomyces yeasts and hydrolyzing enzymes |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | CA2064304A1 Modified enzyme |
| 09/29/1992 | CA1308217C Substrate peptides |
| 09/29/1992 | CA1308021C Chemical sensors employing catalytic antibodies |
| 09/28/1992 | CA2039248A1 Ultra-pure thrombin preparation |
| 09/26/1992 | CA2039017A1 Process for the production of mn-dependant peroxydases |
| 09/23/1992 | WO1992016634A1 A process for producing heme proteins |
| 09/23/1992 | EP0505311A2 A process for producing heme proteins |
| 09/23/1992 | EP0505151A2 Preparation of the penicilline binding protein 2A from staphylococcus aureus 27R, purification and use in a resistant-assay |
| 09/23/1992 | EP0504947A2 Process for the production of beta glucanase from the mould Mucor miehei and beta glucanase produced by this process |
| 09/23/1992 | EP0504798A1 Method of production of high amounts of glutaryl acyclase |
| 09/23/1992 | EP0504574A1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same |
| 09/23/1992 | EP0504421A1 D-pantolactone hydrolase and production thereof |
| 09/23/1992 | EP0504349A1 BIOCONVERSIONS CATALYZED BY THE TOLUENE MONOOXYGENASE OF $i(PSEUDOMONAS MENDOCINA) KR-1 |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | CA2106485A1 Process for producing heme proteins |
| 09/23/1992 | CA2060569A1 1,2,4-oxadiazole derivatives having monoamine oxidase b enzyme-inhibitory activity and method for preparing same |
| 09/22/1992 | US5149783 Polypeptide capable of being cleaved by protease of rhinovirus for use as a test system for inhbitors of viral proteases and an assay for identifying viral inhibitors |
| 09/22/1992 | US5149657 Escherichia coli expression vector encoding bioadhesive precursor protein analogs comprising three to twenty repeats of the decapeptide (Ala-Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys) |
| 09/22/1992 | US5149651 Culturing in a medium supplemented with chelating agent containing aspartate beta-decarboxylase under aerobic condition |
| 09/22/1992 | US5149648 Enzymes employed for producing pulps |
| 09/22/1992 | US5149647 Micrifltration; selective adsorption on strong cation exchange resin; successive and selective elution with saline solutions |
| 09/22/1992 | US5149646 Ultrafiltration, separation on a carboxy-sulfon cation exchange column |
| 09/22/1992 | US5149644 Process for the release of poly(3-hydroxy carboxylic acids) |
| 09/22/1992 | US5149635 Messenger RNA stabilization in animal cells |
| 09/22/1992 | US5149533 Genetically engineered human tissue plasminogen activator having increased half-life, and increased clot lysis activity and greater specificity for binding fibrin |
| 09/20/1992 | CA2063316A1 Dna and amino acid sequence of penicillin binding protein 2a from staphylococcus aureus strain 27r and derivatives for use in purification thereof and assay for compounds effective against methicillin resistant organisms |
| 09/19/1992 | WO1992016640A1 Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/17/1992 | WO1992015834A1 Method for cleaning of heat exchangers |
| 09/17/1992 | WO1992015694A1 Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
| 09/17/1992 | WO1992015693A1 Chimeric tar enzyme construction for hiv therapy |
| 09/17/1992 | WO1992015687A1 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 09/17/1992 | WO1992015686A1 Modified factor vii |
| 09/17/1992 | WO1992015685A1 Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 09/17/1992 | WO1992015676A1 Somatic cell gene therapy |
| 09/17/1992 | WO1992015673A1 Cloning and expression of renilla luciferase |
| 09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/17/1992 | WO1992015604A1 Anti-testosterone compounds and method of use thereof |
| 09/17/1992 | WO1992015551A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
| 09/17/1992 | WO1992015327A1 Recombinant double chain immunotoxins |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992013053A3 Detergent compositions with high activity cellulase and softening clays |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | CA2105674A1 Method for cleaning of heat exchangers |
| 09/17/1992 | CA2105171A1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
| 09/16/1992 | WO1992016221A1 Pegylation of polypeptides |
| 09/16/1992 | EP0503520A1 Cyclic ketal derivatives |
| 09/16/1992 | EP0503419A1 Process for production of MA |
| 09/16/1992 | EP0503346A2 Method of improvement of stability of high alkaline proteases |
| 09/16/1992 | EP0503045A1 Cloning cartridges and expression vectors in gram-negative bacteria |
| 09/16/1992 | EP0502995A1 Dna, constructs, cells and plants derived therefrom. |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0494207A4 Thermostable purified endoglucanases from thermophilic bacterium acidothermus cellulolyticus |
| 09/16/1992 | EP0267224B1 Process for the production of a polypeptide |
| 09/16/1992 | CN1064503A Radiation method for preservation activity and sterilization of food grade saccharidase preparation |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1991013989A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | US5147803 Using (di- or tri)peptides |
| 09/15/1992 | US5147800 Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria |
| 09/15/1992 | US5147796 Alkaline pullulanase Y having α-amylase activity |
| 09/15/1992 | US5147795 Alkaline pullulanase from bacillus sp. ferm p-10887 |
| 09/15/1992 | US5147794 Type II restriction endonuclease obtainable from Kluyvera ascorbata and a process for producing the same |
| 09/15/1992 | US5147793 Biocatalytic oxidation using soybean peroxidases |
| 09/15/1992 | US5147792 Method of shifting the fatty acid distribution in plastids towards shorter-chained species by using thioesterase II and acyl carrier protein |
| 09/15/1992 | US5147790 Tissue plasminogen activator, biosynthesis |
| 09/15/1992 | US5147789 For production of polypeptide analog of an animal growth hormone |
| 09/15/1992 | US5147643 DNA sequences encoding human t-PA substituted at position 275 or at positions 275 and 277 and pharmaceutical compositions |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA2078010A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated |
| 09/15/1992 | CA1307485C Protection of proteins and the like |
| 09/15/1992 | CA1307481C Gal operon of streptomyces |
| 09/15/1992 | CA1307466C Inhibition of protein kinase c by long-chain bases |
| 09/13/1992 | WO1992016530A1 Cyclic ketal derivatives |
| 09/13/1992 | CA2106072A1 Cyclic ketal derivatives |